Hydroxypropyl-beta-cyclodextrin - CAS 107745-73-3

Hydroxypropyl-beta-cyclodextrin, also known as Hydroxypropyl-beta-cyclodextrin; THPB; HP-beta-CD; HPbCD; HP-beta-CyD; VTS-270; HPbetaCD; HPbetaCyD, is a drug candidate potentially for the treatment of Niemann-Pick type C diseases. In April 2009, hydroxypropyl-beta-cyclodextrin (HPbCD) was first approved.

Others, SARS-CoV

Others, Microbiology/Virology

107669

C63H112O42

1541.547

[H][C@@]12O[C@H](COCC(C)O)[C@@]([H])(O[C@@]3([H])O[C@H](COCC(C)O)[C@@]([H])(O[C@@]4([H])O[C@H](COCC(C)O)[C@@]([H])(O[C@@]5([H])O[C@H](COCC(C)O)[C@@]([H])(O[C@@]6([H])O[C@H](COCC(C)O)[C@@]([H])(O[C@@]7([H])O[C@H](COCC(C)O)[C@@]([H])(O[C@@]8([H])O[C@H](COCC(C)O)[C@@]([H])(O1)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)C2O

-20°C

Ice Packs

Small Compound